Davide Laghezza

Davide Laghezza is a Senior Manager of Global Regulatory Strategy in Neuroscience at Jazz Pharmaceuticals, a position held since April 2022, focusing on cannabinoids and neuroscience. Prior to this role, Davide gained extensive experience at Gilead Sciences from January 2017 to April 2022, progressing from Regulatory Affairs Associate II roles to Manager of UK & Ireland Regulatory Affairs within virology, especially HIV and liver diseases. Previous positions include a Regulatory Affairs Associate at Eli Lilly and Company, with expertise in oncology, diabetes, and immunology. Academic credentials include a Master's degree in Pharmacy from Sapienza Università di Roma, a postgraduate master in Pharmacovigilance and Drug Regulatory Affairs from Università degli Studi di Verona, and a pharmacy internship at Farmacia Caprino. Research experience encompasses pharmaceutical chemistry with work on drug delivery systems, including nanoparticles and vesicles for targeted therapies.